Health Canada approved TLANDO for testosterone replacement therapy in adult men with hypogonadism, with Lipocine’s commercial ...

Testosterone replacement therapy has largely relied on delivery methods that come with practical tradeoffs. Injections ...

The HSA and FSA eligible program includes physician oversight, lab testing every six months, and medication and supplies ...

Compare five Bonita Springs TRT clinics on lab monitoring, credentials, pricing, and safety standards before starting your ...

Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that, through Lipocine's licensing partner Verity ...

Germany: A retrospective real-world cohort study has found that off-label testosterone therapy in men without evidence of ...

TLANDO is approved by Health Canada as a testosterone replacement therapy in adult males indicated for conditions associated with a deficiency or absence of endogenous testosterone (male hypogonadism) ...

Lipocine Inc (NASDAQ:LPCN) shares rose 30% in premarket trading Wednesday after Health Canada approved the company's oral testosterone drug TLANDO.

A strategic letter of intent with an established U.S. 503A compounding pharmacy gives The More Life Company (CSE: MLCO, OTC: ...

A recent BBC report described women posing as men to get hold of testosterone gel, hoping to improve their menopause symptoms, because female testosterone products are not easily available to them.

PRNewswire/ -- ("Hydreight" or the "Company") (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) today announced that Insu Therapeutics ...

A pre-registered scoping review of 24 studies covering more than 5,500 transgender and gender-diverse people finds chronic ...